Teaching the immune system to control HIV

Дата публикации: 17-09-2026 19:00:08

There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives. Results from a clinical trial led by Rockefeller, Imperial College London, and the University of Oxford (RIO) have offered a new strategy, suggesting that just one or two doses of broadly neutralizing antibodies (bNAbs) can suppress the virus long term, keeping it at undetectable levels for months and even years.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blocking immune cells' path into the brain limits neurodegeneration	0	6.69	28-09-2026
2	Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation	0	8.94	20-09-2026
3	Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses	0	9.6	23-09-2026
4	Boosted Bacille Calmette-Guérin vaccine strategy significantly reduces tuberculosis relapse, scientists find	0	9.58	17-09-2026
5	Wiskott-Aldrich syndrome: Long-term results of gene therapy developed	0	13.28	24-09-2026
6	Knoxville Celiac community offers support while raising awareness for the disease	0	10.41	28-09-2026
7	Immune cells that may help sustain type 1 diabetes attack identified	0	11.06	22-09-2026
8	Restoring brain immune balance opens new avenue for Alzheimer's treatment	0	6.71	21-09-2026
9	Newly discovered inflammatory cell signaling could open the door to autoimmune disease treatments	0	10.81	23-09-2026
10	Scientists overcome key barrier to self-amplifying vaccines	0	9.51	28-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.4. Источник: medicalxpress.com.